LIGAND PHARMACEUTICALS INC (LGND)
Data as of , from SEC Form 4 filings.
See up to 3 months of LGND. The 7-day demo opens the 1M and 3M ranges and puts LGND on your watchlist.
Start 7-day demoLatest LGND insider trades
About LIGAND PHARMACEUTICALS INC (LGND)
LIGAND PHARMACEUTICALS INC files with the SEC under CIK 0000886163 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
LGND Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 24 | 54,979 | $16.07M |
| Option exercise | 16 | 86,238 | |
| Tax withholding / forfeiture | 1 | 115 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
LGND insider transactions (Form 4)
361 Form 4 filings on record, the earliest from Dec 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John L. Lamattina - Director | Option exercise | Common Stock | 2,406 | $52.30 | $126K | |
| John L. Lamattina - Director | Open-market sale | Common Stock | 2,406 | $123.65 | $298K | |
| John L. Lamattina - Director | Option exercise | Non-Qualified Stock Option (right to buy) | 2,406 | $0.00 | - |
Recent LGND Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MARTINE ZIMMERMANN | Director | 1,200 | $342K | View on EDGAR | |
| ANDREW REARDON | Officer | 15,000 | $4.30M |
Stock trades in LGND disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase |
LGND insider trading FAQ
What is the latest insider trade for LGND?
LIGAND PHARMACEUTICALS INC (LGND) had 7 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for LGND runs to 61 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LGND stock?
No insider purchases of LGND were filed in the last 90 days.
How many insiders are selling LGND stock?
24 insider sales of LGND were filed in the last 90 days, totaling $16.07M.
Where can I see LGND SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LGND Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andrew Reardon view on EDGAR
- - Martine Zimmermann view on EDGAR
- - Martine Zimmermann view on EDGAR
- - Andrew Reardon view on EDGAR
- - Octavio Espinoza view on EDGAR
- - Jason Haas view on EDGAR
- - Andrew Reardon view on EDGAR
- - Andrew Reardon view on EDGAR
- - Octavio Espinoza view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where LGND's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LGND with a 7-day demo
- LGND on your watchlist
- Every LGND Form 4 filing on record
- Up to 3 months of LGND price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive